The Weekly Roundup: February 10-14
In case you missed it, this week we had news about rezpegaldesleukin’s fast track designation for AD, bimekizumab’s long-term efficacy for HS, conference recaps of SBS and MOPD, and more.
Related Articles
Advancing Care With Laser and Light-Based Technology in Dermatology
Karan Lal, DO, MS, FAAD; Cheri Frey, MD; Corey Hartman, MD, FAAD; Sophia Reid, MD, and Sophia Reid, MD, Medical experts explains how laser therapy…
LGBTQ+-Inclusive Language in Patient-Reported Outcome Measures for Acne Vulgaris
This qualitative study examines whether patient-reported outcomes measures for acne incorporate LGBTQ+-inclusive language.
Psychiatry Update 2024
We are pleased to invite you to the 2024 Psychiatry Update – a three-day meeting with renowned faculty and informative presentations on bipolar disorder, MDD,…
Top 5 Articles of the Week: February 9-14
Explore the top headlines of the week including the expanding role of NPs and PAs, a clinician’s guide to chemical peels, and recently announced therapeutic…
Post-Hoc Analysis of ALLEGRO-2b/3 Trial Highlights Patient-Reported Outcome Improvements
Clinicians observed a positive relationship between scalp hair regrowth and downstream treatment benefits for patients with alopecia areata.
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
Should “Advanced Practice Provider” Represent Both PAs and NPs?
Uniting all professions should be the goal as it concerns the patient and the access to care.
Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma
Trauma-induced melanocyte implantation can lead to subcutaneous melanoma, mimicking melanoma of unknown primary but with distinct diagnostic criteria.